Search company, investor...
Inito company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Seed | Alive

Total Raised


Last Raised

$150K | 4 yrs ago

About Inito

Inito is building a small device that enables smartphones to perform lab-grade fertility diagnostic tests at home. The device is based on the company's patent-pending 'Flat-lens' technology and comes with the Inito Reader, App, and test strips.

Inito Headquarters Location

1st Floor, #285, 11th Main Koramangala 4th Block

Bengaluru, 560034,


+1 202-852-7676

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Inito

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Inito is included in 6 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,476 items

Startups focused on providing products and services catering to women's health and wellbeing.


Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.


Medical Devices

8,487 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,764 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

8,881 items

Latest Inito News

These Indian medtech startups are changing how women take care of their health

Aug 19, 2021

However, couples leaning towards IVF think twice before opting in for the procedure, as the entire process is quite expensive. A typical IVF procedure costs anywhere between INR 250,000 (USD 3,356) and INR 300,000 (USD 4,027). And since its success is largely left to chance, most couples typically get successfully pregnant after a minimum of two to three IVF cycles. Dr. Geetha Manjunath, CEO & CTO of Niramai posing with the thermal scanner. Photo courtesy of Niramai. “My wife and I made the decision to go for an IVF after three months of trying to have timely intercourse. We had to consider the fact that each cycle of IVF cost two months of our salary,” Giri Philip, a software developer at Hewlett Packard, told KrASIA. Dr. Gayathri Karthik, the head of the department and consultant of obstetrics & gynecology at Manipal Hospitals, said, “Women who cannot conceive naturally and opt for IVF need an average of two to three cycles for a successful pregnancy.” GoHealthe claims it is possible to decrease the number of cycles using its product. GoHealthe uses AI and image processing to determine the healthiest embryo. The software is trained on over 8,000 images of embryos collected from around the world. The company has partnered with 11 clinics globally, and every time its partner clinic uploads an image of a patient’s embryo, the software scans and compares the morphological features of the embryos to give a score out of ten, which corresponds to the likelihood of a successful pregnancy. Moreover, it can rank embryos that it has never seen before and improve the accuracy of the selection process. Since the predictions are based less on the opinion of embryologists and more on unassailable data, patients tend to feel more confident. Dr. Michelle Perugini, founder of Presagen, the parent company of GoHealthe, said, “With AI, we can identify the most viable embryos and help women conceive faster.” Implanting embryos that increase the chances of pregnancy not only reduces the number of IVF cycles needed but also helps prevent emotional burnout of women and couples. However, turning to IVF is the last resort for couples wanting to become parents. The first step for women who face trouble getting pregnant is to try during their ovulation cycle. With respect to ovulation, most women believe that they can get pregnant close to the 14th day of their menstruation cycle. This assumption is incorrect, as ovulation varies from woman to woman, and the cycle is controlled by an individual’s hormone levels. LH (Luteinizing Hormone), a key fertility hormone, rises 24–36 hours before ovulation and is a strong predictor of a woman’s fertility period. Bengaluru-based company Inito, which manufactures fertility testing kits, measures estrogen and LH levels—present in urine—to accurately predict a woman’s fertile days. Its testing kit, which received regulatory clearance from the US Food and Drug Administration last year, is a small device that connects with smartphones to provide customers with information regarding their ovulation cycle and can point out peak fertility days. Inito claims to be able to naturally increase the chances of pregnancy by 89%. Tech to the aid When it comes to women’s health, medical conditions such as infertility, Polycystic Ovary Syndrome (PCOS), and breast cancer have been on the rise over the past decade. Mammography, the process of using low X-rays to diagnose breast cancer, is invasive, painful, and comes with a risk of radiation, which causes many women to shy away from getting tested. However, doctors say this hereditary disease can be largely controlled if detected early. When 25-year-old Susan Matthew, whose sister was diagnosed with breast cancer seven years ago, decided to get the checkup done as a precautionary measure, she chose to go with Bengaluru-based medtech startup Niramai’s non-invasive and painless diagnosis technique. “Stage zero detection has a five-year survival rate of 95%, whereas stage three detection has a five-year survival rate of 10%. This drastic difference in survival rate, quality of health, and treatment efficacy are all signs that women should be proactive about their breast health,” said Dr. Geetha Manjunath, founder of Niramai. While a typical mammogram identifies breast cancer only after visible lumps have been formed, Niramai’s Thermalytix tool, which uses AI and thermal scanning, can identify breast cancer well in advance. Last year during the pandemic, the company launched a home screening service for women who are due for their annual preventive diagnosis as well as for first-time customers. Niramai has diagnosed 36,000 women so far and is present in 14 cities with over 50 hospitals using its breast screening technology. As these companies see an uptick in terms of usage from patients as well as doctors and hospitals, they have started attracting the attention of top-tier venture funds. In 2019, Niramai raised USD 6 million in Series A funding led by Japanese VC firm Dream Incubator, Beenext, Flipkart co-founder Binny Bansal, pi Ventures, and Axilor Ventures, among others. The ovulation testing kit manufacturer Inito is backed by Y Combinator and has raised USD 1.8 million from several angel investors. Last month, Veera Health, a digital health platform for women, received USD 3 million from Sequoia Capital India’s Surge, Global Founders Capital, Y Combinator, CloudNine Hospitals’ co-founder Rohit M.A, Tinder India Head Taru Kapoor, and other angels. Founded by sisters Shobhita and Shashwata Narain in August 2020, Veera Health connects PCOS patients with doctors, dieticians, and caregivers to create a personalized treatment and health plan. It claims 110 million women suffering from PCOS in India have used its platform. “I was extremely frustrated by how long it took me to get diagnosed with PCOS, get proper medical advice to manage my condition. Even after trying multiple doctors, I felt like I was in the dark about how to treat my symptoms,” said Shobhita Narain, COO and co-founder of Veera Health. Women in India face a lot of stigma and judgment, even from the doctors, when it comes to treating their health. “There’s definitely a lot of judgment in the Indian context as well. We hear story after story from our customers about how they were body-shamed or told to get married instead of treating PCOS,” Shobhita said. Share

Inito Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Inito Rank

  • When was Inito founded?

    Inito was founded in 2015.

  • Where is Inito's headquarters?

    Inito's headquarters is located at 1st Floor, #285, 11th Main, Bengaluru.

  • What is Inito's latest funding round?

    Inito's latest funding round is Seed.

  • How much did Inito raise?

    Inito raised a total of $1.15M.

  • Who are the investors of Inito?

    Investors of Inito include Y Combinator.

  • Who are Inito's competitors?

    Competitors of Inito include Hormona and 1 more.

You May Also Like

Mira Logo

Quanovate aims to make home healthcare more personal, accurate, and reliable, and to empower people to become more actively involved in managing their health. The company is the creator of Mira, an ovulation and fertility tracker.

Everly Health Logo
Everly Health

Everly Health provides an e-commerce platform that enables customers to buy a variety of test kits online, collect their sample at home, and get informative results without visiting a lab or doctor's office. The platform offers various at-home lab tests including sexual health, thyroid, metabolism, men's health, and breast milk DHA testing, which the company is the exclusive provider of in the U.S. It was formerly known as Everlywell.

Oova Logo

Oova​ is a biomedical technology company for women's health that uses smart connected devices to actively monitor hormone levels and help manage women's fertility health.


Global public relations and communications company specializing in traditional and nontraditional marketing techniques.

inne Logo

inne is a biotechnology startup helping women track their fertility in a more accurate and convenient way. The company uses biochemistry to track hormones and an app to help users understand what they mean and how they affect everyday fertility. Its flexible, 30-second, at-home saliva test predicts and confirms a user's ovulation using actual hormone levels. The company was founded in 2016 and is based in Berlin, Germany.

Proov Logo

MFB Fertility empowers couples to take control of their fertility by providing them ways to measure reproductive hormones at home. The Proov test allows women to track progesterone and identify hormonal problems that cause infertility and miscarriage while identifying and treating issues faster and with less cost than fertility centers and IVF treatments.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.